These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 5093379

  • 21. [The combination sulfamethoxazole-trimethoprim in vitro].
    Linzenmeier G, Neussel H.
    Zentralbl Bakteriol Orig A; 1972 Sep; 221(4):511-26. PubMed ID: 4144946
    [No Abstract] [Full Text] [Related]

  • 22. [Sensitivity to Septrin of microorganisms causing urinary tract infections].
    Ganczarski A, Augustyniak B, Kloczkowski K, Prelich A, Stapor K.
    Pol Tyg Lek; 1972 Oct 30; 27(44):1719-21. PubMed ID: 4639632
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of chronic urinary salmonella carriers with trimethoprim-sulphamethoxazole.
    Bassily S, Farid Z, Lehman JS, Ayad N, Sippel J.
    J Trop Med Hyg; 1972 Nov 30; 75(11):227-9. PubMed ID: 4645694
    [No Abstract] [Full Text] [Related]

  • 24. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
    Gärtner H, Dieterich F.
    Arzneimittelforschung; 1973 Apr 30; 23(4):597-600. PubMed ID: 4197072
    [No Abstract] [Full Text] [Related]

  • 25. [Synergism of colistin and trimethoprim against Proteus bacteria in vivo].
    Freiesleben H.
    Int J Clin Pharmacol; 1972 Aug 30; 6(3):285-90. PubMed ID: 4567539
    [No Abstract] [Full Text] [Related]

  • 26. Joint trimethoprim and sulphamethoxazole resistance in bacteria infected with R factors.
    Pinney RJ, Smith JT.
    J Med Microbiol; 1973 Feb 30; 6(1):13-9. PubMed ID: 4570475
    [No Abstract] [Full Text] [Related]

  • 27. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, Deb M, Aggarwal P, Rubino S.
    J Antimicrob Chemother; 2006 Dec 30; 58(6):1139-44. PubMed ID: 17071955
    [Abstract] [Full Text] [Related]

  • 28. [Liver functional state and antibacterial activity of trimethoprim-sulfamethazole in blood, bile and urine in humans].
    Neuman M, Kazmierczak A, Charbonnier A.
    Therapie; 1972 Dec 30; 27(6):1069-80. PubMed ID: 4661222
    [No Abstract] [Full Text] [Related]

  • 29. [Activity of the trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice. Histochemical study].
    Cellesi C, Barberi A, Terragna A.
    Boll Ist Sieroter Milan; 1973 Dec 30; 52(1):70-6. PubMed ID: 4714452
    [No Abstract] [Full Text] [Related]

  • 30. [Activity of the trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice. Histological and immuno-histological study].
    Terragna A, Cellesi C, Barberi A.
    Boll Ist Sieroter Milan; 1973 Dec 30; 52(1):60-9. PubMed ID: 4576904
    [No Abstract] [Full Text] [Related]

  • 31. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R, Koch UJ.
    Chemotherapy; 1973 Dec 30; 18(4):242-52. PubMed ID: 4571975
    [No Abstract] [Full Text] [Related]

  • 32. Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.
    Bushby SR.
    Postgrad Med J; 1969 Nov 30; 45():Suppl:10-8. PubMed ID: 5361305
    [No Abstract] [Full Text] [Related]

  • 33. [Effect of the drug combination trimethoprim-sulfamethoxazole on the intestinal flora of man in short- and long-term administration].
    Knothe H.
    Arzneimittelforschung; 1973 May 30; 23(5):704-8. PubMed ID: 4197002
    [No Abstract] [Full Text] [Related]

  • 34. [Response of Salmonella typhi and S. paratyphi B strains from the years 1968/70 and 1974 to antibiotics].
    Brandis H, Andries L.
    Med Monatsschr; 1975 Jan 30; 29(1):6-9. PubMed ID: 235717
    [No Abstract] [Full Text] [Related]

  • 35. Sensitivity testing with trimethorpim-sulphamethoxazole.
    Bushby SR.
    Med J Aust; 1973 Jun 30; 1(2):Suppl:10-8. PubMed ID: 4199527
    [No Abstract] [Full Text] [Related]

  • 36. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
    Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M.
    Diagn Microbiol Infect Dis; 2006 Apr 30; 54(4):299-303. PubMed ID: 16466897
    [Abstract] [Full Text] [Related]

  • 37. Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region?
    Walther-Rasmussen J, Høiby N.
    Epidemiol Infect; 2011 Aug 30; 139(8):1281-3; author reply 1283. PubMed ID: 21050501
    [No Abstract] [Full Text] [Related]

  • 38. Regression line analysis of the synergistic effect for the combination of trimethoprim-sulphamethoxazole.
    Dornbusch K.
    Chemotherapy; 1971 Aug 30; 16(4):229-38. PubMed ID: 5121717
    [No Abstract] [Full Text] [Related]

  • 39. [Antibacterial activity of the combination trimethoprim-sulfamethoxazole compared with antibiotics].
    Böhni E.
    Schweiz Med Wochenschr; 1969 Oct 18; 99(42):1505-10. PubMed ID: 4903288
    [No Abstract] [Full Text] [Related]

  • 40. [In vitro testing of Ro 6-2580-9 or Ro 6-2580-11 with the disc test].
    Holl KM.
    Chemotherapy; 1969 Oct 18; 14():Suppl:30-7. PubMed ID: 5379871
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.